The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSQN.L Regulatory News (SQN)

  • There is currently no data for SQN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment Update

23 Jul 2018 10:25

RNS Number : 4406V
SQN Asset Finance Income Fund Ltd
23 July 2018
 

23 July 2018

 

SQN Asset Finance Income Fund Ltd

Investment Update Following the 30 June Financial Year-end

 

SQN Asset Finance Income Fund Limited (the "Company"), the leading diversified equipment leasing fund listed in the UK, is pleased to provide this update following the conclusion of the financial year-end 30 June 2018 and in advance of releasing the Annual Report and Accounts in October 2018.

Responding to requests for a higher level of disclosure for an asset class still relatively new to the London-listed market, the Company and the Manager have endeavoured to increase the frequency and level of detail of market communications. In continuation of this effort, the Company provides this update.

In the half-year report for 31 December 2017 released in March 2018, the Company identified six investments that were "Past Due not Impaired". In conjunction with the release of the half-year report, the Manager communicated to the market that, in the normal course of generating yields at the levels necessary to sustain a 7.25% dividend, there would always be transactions requiring attention. Further, it was reported that, based on the collateralised nature of the Company's investment strategy, workouts do not necessarily result in impairments and, on occasion, have the potential for additional returns to be realised.

The Company is pleased to report that four out of the six accounts have been restructured into an improved position and confidence remains high on a positive outcome for the remaining two investments which includes the Suniva investment and the relatively small investment in the portfolio of telecommunication towers.

The Company is further pleased to report that no new material issues have arisen in the portfolio. While the outlook remains positive, it is expected that new issues will inevitably present themselves at which time, the Company hopes that the market will see these as being in the normal course and recognise that, given time, they will likely be resolved.

The Company is also pleased to announce that more than 77% of the C Share capital has been deployed and expects to increase the dividend to an annualised rate of 7.25 in August 2018.

Individual Transaction Updates (In order as disclosed in the half-year report and referenced above):

Solar (Suniva)

The Company has continued discussions with multiple counterparties seeking to lease or purchase the Suniva equipment. The recent developments in the United States have provided additional support for domestic manufacturers which should strengthen Suniva's market position. Furthermore, efforts have intensified in pursuing the guarantee with subpoenas being issued to officers of the guarantor. The Board, as advised by the Manager, continues to believe that a full recovery of the Suniva investment will be achieved. This is expected to be through the lease or sale of the Suniva equipment and, to the extent required, by pursuing the guarantee. The Company has examined the minimum expected recovery under the lease or sale of the Suniva equipment and, considering the potential time required to realise the guarantee, the Company has reflected an impairment of £2.4m to the Suniva investment to account for the risk adjusted time value of money on such proportion of the investment should a full recovery not be achieved through a sale or re-lease.

Medical Equipment

At 31 December 2017, it was reported that a hospital for which the Company provided financing had filed for reorganization under Chapter 11 of the US Bankruptcy Code. The hospital emerged from bankruptcy in July having been purchased by a financial investor with the ultimate intention of reselling the hospital at a multiple of its acquisition price. Simultaneously with this transaction, the Company has entered into a new secured $5m note, with enhanced collateral, with the hospital and has also been granted a 15% equity interest in the hospital. The interest rate on the note is 5%.

 

Transportation

The Company had previously reported that it provided financing for four multi-purpose vessels at a relatively low loan to value. The Company made the decision to force a sale of those vessels which resulted in a series of competitive bids and a price sufficient to pay the Company all outstanding principal and interest. The Company is in the documentation phase of closing.

 

IT & Telecom

The Company provided financing for a portfolio of telecommunication towers. The CEO of the borrower unexpectedly passed away which resulted in a delay in selling or refinancing the assets which caused the loan to go into default. The new management of the operator is in the process of arranging to refinance the Company's assets and has received terms sheets from four lenders. A resolution to this matter is expected by September 2018. Until then, the investment remains insured by an investment grade reinsurance syndicate.

 

Hospitality (Snoozebox)

The Company has provided previous updates on the Snoozebox restructuring. Since the date of the last update, the investment has continued to generate regular income and is a now fully performing under the terms of the new lease.

 

Agriculture (Anaerobic Digestion Plant)

At 31 December 2017, it was reported that an anaerobic digestion plant representing approximately 7.5% of NAV and subject to a finance lease was past due. The lease is now current and the plant is operating in accordance with the planned ramp-up.

 

 

Enquiries:

SQN Capital Management, LLC

01932 575 888

Neil Roberts

Jeremiah Silkowski

 

Winterflood Securities Limited

020 3100 0000

Neil Langford

Chris Mills

 

Buchanan

020 7466 5000

Charles Ryland

Henry Wilson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGUGPMUPRUBW
Date   Source Headline
28th Dec 201611:36 amRNSDirector/PDMR Shareholding
23rd Dec 20161:12 pmRNSDirector/PDMR Shareholding
19th Dec 20167:00 amRNSMonthly NAV and Dividend
8th Dec 20167:00 amRNSResult of Placing, Open Offer and Offer for Subs
6th Dec 20168:00 amRNSResult of EGM
2nd Dec 20163:31 pmRNSHolding(s) in Company
24th Nov 201612:00 pmRNSResult of AGM
16th Nov 201611:00 amRNSHolding(s) in Company
15th Nov 20167:00 amRNSMonthly NAV and Dividend
9th Nov 20167:00 amRNSPlacing, Open Offer and Offer for Subscription
8th Nov 20162:30 pmRNSPublication of a Prospectus
2nd Nov 20164:21 pmRNSHolding(s) in Company
1st Nov 20167:00 amRNSTotal Voting Rights
28th Oct 20167:00 amRNSNotice of AGM
27th Oct 20167:00 amRNSIntention to Raise Capital
26th Oct 20164:32 pmRNSHolding(s) in Company
21st Oct 20167:00 amRNSNAV, Dividend and Update on C Share Conversion
14th Oct 20167:00 amRNSC Share Investment Update
10th Oct 20163:41 pmRNSHolding(s) in Company
21st Sep 20166:00 pmRNSAnnual Financial Report
21st Sep 20167:00 amRNSMonthly NAV and Dividend
15th Sep 201612:06 pmRNSHolding(s) in Company
24th Aug 20164:49 pmRNSHolding(s) in Company
18th Aug 20167:00 amRNSMonthly NAV and Dividend
21st Jul 20167:00 amRNSMonthly NAV and Dividend
21st Jun 20167:00 amRNSMonthly NAV and Dividend
20th Jun 20169:15 amRNSDirector Declaration
23rd May 20167:00 amRNSMonthly NAV and Dividend
10th May 201612:32 pmRNSHolding(s) in Company
21st Apr 20167:00 amRNSMonthly NAV and Dividend
21st Mar 20167:00 amRNSMonthly NAV and Dividend
22nd Feb 20167:00 amRNSMonthly NAV and Dividend
22nd Feb 20167:00 amRNSHalf Yearly Report
28th Jan 20167:00 amRNSDisclosure of Home Member State
27th Jan 20164:55 pmRNSHolding(s) in Company
22nd Jan 20167:00 amRNSMonthly NAV and Dividend
12th Jan 20167:00 amRNSTransactions in a Close Period
22nd Dec 20151:00 pmRNSDirector Declaration
21st Dec 20157:00 amRNSMonthly NAV and Dividend
14th Dec 201512:00 pmRNSHolding(s) in Company
1st Dec 20153:36 pmRNSTotal Voting Rights
30th Nov 201511:20 amRNSHolding(s) in Company
23rd Nov 201510:17 amRNSHolding(s) in Company
20th Nov 20153:00 pmRNSFCA Listing Rules
20th Nov 20157:00 amRNSMonthly NAV and Dividend
19th Nov 20154:08 pmRNSResult of AGM
12th Nov 201511:01 amRNSTotal Voting Rights
9th Nov 201511:07 amRNSDirector/PDMR Shareholding
4th Nov 20157:00 amRNSResult of Placing
21st Oct 20157:00 amRNSMonthly NAV and Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.